Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
57KRW
3.86 BKRW
122.54 BKRW
34.06 M
About HWAIL PHARM. CO., LTD
Sector
Headquarters
Hwaseong
Employees (FY)
152
Website
Founded
1980
ISIN
KR7061250007
FIGI
BBG000MMK021
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others. The company was founded on November 18, 1980 and is headquartered in Hwaseong, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 061250 is 1506 KRW — it has decreased by 1.12% in the past 24 hours. Watch HWAIL PHARM. CO., LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HWAIL PHARM. CO., LTD stocks are traded under the ticker 061250.
061250 stock has fallen by 5.28% compared to the previous week, the month change is a 4.98% fall, over the last year HWAIL PHARM. CO., LTD has showed a 30.92% decrease.
061250 reached its all-time high on Aug 3, 2007 with the price of 6233 KRW, and its all-time low was 500 KRW and was reached on Jun 23, 2004. View more price dynamics on 061250 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
061250 stock is 1.94% volatile and has beta coefficient of 0.47. Track HWAIL PHARM. CO., LTD stock price on the chart and check out the list of the most volatile stocks — is HWAIL PHARM. CO., LTD there?
Today HWAIL PHARM. CO., LTD has the market capitalization of 112.93 B, it has increased by 2.31% over the last week.
Yes, you can track HWAIL PHARM. CO., LTD financials in yearly and quarterly reports right on TradingView.
HWAIL PHARM. CO., LTD is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
061250 net income for the last quarter is 1.16 B KRW, while the quarter before that showed −1.82 B KRW of net income which accounts for 163.47% change. Track more HWAIL PHARM. CO., LTD financial stats to get the full picture.
As of May 29, 2024, the company has 152.00 employees. See our rating of the largest employees — is HWAIL PHARM. CO., LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HWAIL PHARM. CO., LTD EBITDA is 3.24 B KRW, and current EBITDA margin is 2.52%. See more stats in HWAIL PHARM. CO., LTD financial statements.
Like other stocks, 061250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HWAIL PHARM. CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HWAIL PHARM. CO., LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HWAIL PHARM. CO., LTD stock shows the sell signal. See more of HWAIL PHARM. CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.